Evidence map›Paper›PMID 37971282›Full record

ArticleImmunoHorizons2023

Missing a "Missing Self" Mechanism: Modeling and Detection of Ly49 Expression in Canine NK Cells.

Alicia A Gingrich, Aryana M Razmara, Phillip W Gingrich, Robert B Rebhun, William J Murphy, Michael S Kent, C Titus Brown, Justin B Siegel, Robert J Canter

Open access · goldAbstract read
In one paragraph

Article in ImmunoHorizons, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Translational History and Hope of Immunotherapy of Canine Tumors.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Alicia A GingrichDepartment of Surgery, University of California, Davis School of Medicine, Sacramento, CA.
Aryana M RazmaraDepartment of Surgery, University of California, Davis School of Medicine, Sacramento, CA.
Phillip W GingrichDepartment of Biochemistry and Molecular Medicine, University of California, Davis School of Medicine, Sacramento, CA.
Robert B RebhunDepartment of Surgical and Radiological Sciences, University of California, Davis School of Veterinary Medicine, Davis, CA.ORCID 0000-0002-8047-3494
William J MurphyDepartment of Dermatology, University of California, Davis School of Medicine, Sacramento, CA.
Michael S KentDepartment of Surgical and Radiological Sciences, University of California, Davis School of Veterinary Medicine, Davis, CA.ORCID 0000-0002-7703-7720
C Titus BrownDepartment of Population Health and Reproduction, University of California, Davis School of Veterinary Medicine, Davis, CA.
Justin B SiegelDepartment of Biochemistry and Molecular Medicine, University of California, Davis School of Medicine, Sacramento, CA.
Robert J CanterDepartment of Surgery, University of California, Davis School of Medicine, Sacramento, CA.ORCID 0000-0002-3331-5418
University of California, Davis · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Gina M Dayton · 2002 to 2026
$84.9M
Gene Expression Analysis of Dog Natural Killer Cells Following Immunotherapy with Molecularly Targeted Radionuclide therapy or Inhaled IL-15U01CA224166 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CANTER, ROBERT J., REBHUN, ROBERT B · 2017 to 2021
$3.0M
UC Davis Comparative Oncology Training ProgramT32CA251007 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Robert J. Canter, Xinbin Chen · 2020 to 2026
$1.8M
UC Davis Shared Astrios Cell SorterS10OD018223 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SHACKLETT, BARBARA L. · 2015 to 2015
$555k
Shared LSRII Cytometer Equipment Application - UC Davis Stem Cell ProgramS10RR026825 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NOLTA, JAN A. · 2010 to 2010
$500k
Acquisition of Covaris E220 and Sciclone G3 systems for high throughput sequencinS10OD010786 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI COMAI, LUCA · 2012 to 2012
$311k
Gene Expression Analysis of Dog Natural Killer Cells as Immunotherapy TargetR03CA252793 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CANTER, ROBERT J. · 2021 to 2022
$157k
Targeting Lung Tissue Resident NK Cells with Inhaled IL-15 and TIGIT Blockade in OsteosarcomaR03CA270854 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CANTER, ROBERT J. · 2022 to 2023
$151k
Combining Radiation, Allogeneic Natural Killer Immunotherapy, and PD-L1 blockade in Dogs with Naturally-Occurring MelanomaF30CA275317 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RAZMARA, ARYANA · 2023 to 2025
$136k
NCI NIH HHS F30 CA275317NCI NIH HHS P30 CA093373NCI NIH HHS R03 CA252793NCI NIH HHS R03 CA270854NCI NIH HHS T32 CA251007NCI NIH HHS U01 CA224166NCRR NIH HHS S10 RR026825NIH HHS S10 OD010786NIH HHS S10 OD018223
6 · The paper itself

Abstract

NK cells are a key focus in immuno-oncology, based on their ability to eliminate malignant cells without prior sensitization. Dogs are valuable models for translational immunotherapy studies, especially for NK cells, where critical species differences exist between mice and humans. Given that the mechanism for recognition of "self" by canine NK cells is currently unknown, we sought to evaluate expression of Ly49 in canine NK cells using in silico and high-throughput techniques. We interrogated the identified polymorphism/mutation in canine Ly49 and assessed the potential impact on structure using computational modeling of three-dimensional protein structure and protein-protein docking of canine Ly49 with MHC class I (MHC-I). Bulk and single-cell RNA-sequencing analysis was performed to detect gene expression of Ly49/KLRA1 in resting and activated NK cells. Tertiary protein structure demonstrated significant structural similarity to the known murine system. Molecular docking of canine Ly49 with MHC-I was favorable, converging at a single low-energy conformation. RNA sequencing revealed expression of Ly49/KLRA1 in both resting and activated NK cells and demonstrated almost exclusive expression of the gene in the NK cluster at the single-cell level. Despite prior reports of a mutated, nonfunctional canine Ly49, our data support that the protein product is predicted to bind to MHC-I in a comparable conformation to the murine system and is expressed in canine NK cells with upregulation following activation. Taken together, these data suggest that Ly49 is capable of recognizing MHC-I and therefore regulating NK cell function in dogs.

Indexed as

Histocompatibility Antigens Class INeoplasmsAnimalsDogsHumansKiller Cells, NaturalMiceMolecular Docking SimulationNK Cell Lectin-Like Receptor Subfamily AHistocompatibility Antigens Class INK Cell Lectin-Like Receptor Subfamily A

Identifiers

PMID37971282
PMCPMC10696421
OpenAlexW4388736215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.